← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Antigenics, Inc.
Lexington, MA
$1,140,157
Total funding
5
Grants
Funding mix
By agency
NIH$1,140,157 · 5
By mechanism
R44$420,908 · 1
R43$416,708 · 3
R41$302,541 · 1
Investigators at Antigenics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
DEVELOPMENT OF LIPID VACCINES FOR TUBERCULOSIS$420,908
R44 · FY2000 · AI
A P. falciparum MSP1 p42/QS-21 malaria vaccine$302,541
R41 · FY2001 · AI
Heat Shock Protein based vaccine for Tuberculosis$188,719
R43 · FY2003 · AI
CD1 PRESENTED VACCINES TO PREVENT CHLAMYDIA INFECTION$127,989
R43 · FY2000 · AI
LIPID-BASED VACCINES FOR STAPHYLOCOCCUS AUREUS$100,000
R43 · FY2000 · AI